AU2001253560A1 - Methods of treatment - Google Patents

Methods of treatment

Info

Publication number: AU2001253560A1
Authority: AU; Australia
Prior art keywords: treatment; methods
Prior art date: 2000-04-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001253560A

Inventor

Maxwell D. Cummings

Robert W. Marquis Jr.

Yu Ru

Scott K. Thompson

Daniel F. Veber

Dennis S. Yamashita

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-18

Filing date

2001-04-17

Publication date

2001-10-30

2001-04-17 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

2001-10-30 Publication of AU2001253560A1 publication Critical patent/AU2001253560A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AU2001253560A 2000-04-18 2001-04-17 Methods of treatment Abandoned AU2001253560A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US19771700P	2000-04-18	2000-04-18
US60197717		2000-04-18
PCT/US2001/012386 WO2001078734A1 (en)	2000-04-18	2001-04-17	Methods of treatment

Publications (1)

Publication Number	Publication Date
AU2001253560A1 true AU2001253560A1 (en)	2001-10-30

Family

ID=22730469

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001253560A Abandoned AU2001253560A1 (en)	2000-04-18	2001-04-17	Methods of treatment

Country Status (5)

Country	Link
EP (1)	EP1303281A4 (en)
JP (1)	JP2003531122A (en)
AU (1)	AU2001253560A1 (en)
CO (1)	CO5280093A1 (en)
WO (1)	WO2001078734A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002092563A2 (en) *	2001-05-17	2002-11-21	Smithkline Beecham Corporation	Protease inhibitors
JP2006504719A (en) *	2002-10-08	2006-02-09	メルクフロストカナダアンドカンパニー	4-Amino-azepan-3-one compounds as cathepsin K inhibitors useful in the treatment of osteoporosis
JP5587790B2 (en)	2008-01-09	2014-09-10	アミュラセラピューティクスリミティド	Compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE411294T1 (en) *	1998-12-23	2008-10-15	Smithkline Beecham Corp	4-AMINO-AZEPAN-3-ON DERIVATIVES AS PROTEASE INHIBITORS
JP2003513924A (en) *	1999-11-10	2003-04-15	スミスクライン・ビーチャム・コーポレイション	Protease inhibitor
JP2003513928A (en) *	1999-11-10	2003-04-15	スミスクライン・ビーチャム・コーポレイション	Protease inhibitor
WO2001034154A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
EP1231921A4 (en) *	1999-11-10	2004-06-23	Smithkline Beecham Corp	Protease inhibitors
WO2001034565A2 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
JP2003533432A (en) *	1999-11-10	2003-11-11	スミスクライン・ビーチャム・コーポレイション	Protease inhibitor
WO2001034155A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
CZ20023168A3 (en) *	2000-03-21	2003-02-12	Smithkline Beecham Corporation	Protease inhibitors

2001
- 2001-04-16 CO CO01029288A patent/CO5280093A1/en not_active Application Discontinuation
- 2001-04-17 AU AU2001253560A patent/AU2001253560A1/en not_active Abandoned
- 2001-04-17 JP JP2001576034A patent/JP2003531122A/en not_active Withdrawn
- 2001-04-17 WO PCT/US2001/012386 patent/WO2001078734A1/en not_active Ceased
- 2001-04-17 EP EP01927076A patent/EP1303281A4/en not_active Withdrawn

Also Published As

Publication number	Publication date
JP2003531122A (en)	2003-10-21
EP1303281A1 (en)	2003-04-23
CO5280093A1 (en)	2003-05-30
EP1303281A4 (en)	2006-02-15
WO2001078734A1 (en)	2001-10-25

Publication	Publication Date	Title
AU2002257936A1 (en)	2002-12-03	Methods of well treatment
AU2002223827A1 (en)	2002-05-27	Well treatment
AU2002215125A1 (en)	2002-05-27	Well treatment method
AU2001249881A1 (en)	2001-10-23	Method of treating the heart
AU2002332430A1 (en)	2003-02-17	Methods of treating neuropilin-mediated diseases
GB0014969D0 (en)	2000-08-09	Novel method of treatment
AU2001286983A1 (en)	2002-03-13	Method of treatment
AU2002231206A1 (en)	2002-07-01	Treatment of depression
AUPR731901A0 (en)	2001-09-20	Method of treatment
AU2001245414A1 (en)	2001-09-24	Treatment of allergies
AU2001262177A1 (en)	2001-10-23	Method of treatment
AU2001253560A1 (en)	2001-10-30	Methods of treatment
AU2001281465A1 (en)	2001-09-24	Treatment of rosacea
AU4598400A (en)	2000-12-12	Method of treatment
AU2382601A (en)	2001-07-09	Novel method of treatment
HK1056502A (en)	2004-02-20	Methods of treatment
AUPR213000A0 (en)	2001-01-25	Method of treatment
AUPQ949500A0 (en)	2000-09-07	Method of treatment
AUPQ662500A0 (en)	2000-05-04	Method of treatment
AUPQ811200A0 (en)	2000-07-06	Treatment of alopecia
GB0013928D0 (en)	2000-08-02	Methods of treatment
GB0014904D0 (en)	2000-08-09	Methods of treatment
AU2001250000A1 (en)	2002-07-08	Treatment of vitiligo
AUPR750701A0 (en)	2001-09-27	Method of treatment
AUPR542201A0 (en)	2001-06-28	Method of treatment